Joseph C. Sardano, CHIEF EXECUTIVE OFFICER at Sensus Healthcare, Inc. (SRTS), sold 754 shares at $7.50 ($6K) on 2018-06-26, disclosed to the SEC on 2018-06-28.
Scheduled sale ($6k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SRTS | BUY | 2023-09-18 | $29K | — | Filing → |
| SRTS | BUY | 2023-08-08 | $39K | — | Filing → |
| SRTS | BUY | 2023-05-11 | $126K | — | Filing → |